Replies to post #181720 on Biotech Values

[DewDiligence]

…which biotech has the most novel unpartnered (post PoC ) compound in development?

From an investment standpoint, “novel” doesn’t necessarily mean good. My vote is for a product I expect to fail: RVNC’s topical botulinum toxin.